DrFirst buys prior authorization automation platform Myndshft
This will allow DrFirst to accelerate its growth in the specialty medication space
Read more...At a Churchill Club meeting in Mountain View on Thursday, Michael Moritz (Sequoia Capital, two-time Forbes’ Midas List overall winner) had California controller John Chiang in the hotseat for an hour to grill him on the state's finances. When Moritz asked about pension funds, Chiang hinted that venture capital could see even less money than might be hoped from CalPERS and CalSTRS, two of the biggest limited-partner sugar daddies that fuel the Valley's VC firms.
In what appeared to be a bit of on-stage negotiating, Chiang intimated that many “alternative investments” were not “high quality,” and that the standard 2-and-20 fees typically doled out to fund managers (2% of the overall fund value plus 20% of the profits) would have to be re-evaluated.
This will allow DrFirst to accelerate its growth in the specialty medication space
Read more...The company initially raised $3 million in seed funding when it launched in October
Read more...This is the company's first fundraising since 2019 and brings its total capital to $103M
Read more...